Print

Facet Biotech Seeks Other Offers After Biogen Idec, Inc. (Massachusetts) (BIIB) (JOBS) Bid Fails  
12/17/2009 8:05:51 AM

Bookmark and Share

BOSTON, Dec. 17 (Reuters) - Biotechnology company Biogen Idec Inc (BIIB.O) has terminated its bid to acquire Facet Biotech Corp (FACT.O) after Facet shareholders rejected the offer of $17.50 a share.

//-->